Skip to main content
All lobbying clients

MERCK & CO. INC.

Lobbying client · District of Columbia · filed 2025 to 2026

developer, manufacturer and distributor of pharmaceuticals

$300,000 Reported spend
6 Filings counted
1 Firms hired
9 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (165804), not by name.

 Firms hired 1
 Bills named in these filings 9
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    2 filings
  • HR 946
    ORPHAN Cures Act
    2 filings
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    1 filing
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    1 filing
  • HR 1672
    Maintaining Investments in New Innovation Act
    1 filing
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    1 filing
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
    1 filing
  • S 1862
    ORPHAN Cures Act
    1 filing
  • S 891
    Bipartisan Health Care Act
    1 filing
 Reported by year 2 years
  • 2026 $100,000 2 filings
  • 2025 $200,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem